Microarray Market
Microarray Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Software & Services), Type, Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $4.70 BN |
|
Projected Year Value (2030) |
US $9.04 BN |
|
CAGR (2023 - 2030) |
9.8% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Microarray Market is accounted for $4.70 billion in 2023 and is expected to reach $9.04 billion by 2030 growing at a CAGR of 9.8% during the forecast period. In genomics and molecular biology, microarrays are an effective technology that allow for the high-throughput, simultaneous investigation of many genes, proteins, or other substances. The market offers a broad variety of applications in research, diagnostics, and drug development and comprises many types of microarrays, including DNA, protein, and tissue microarrays. Custom microarrays are created by several organizations and researchers to meet their unique research requirements.
According to a research study published by the Royal Society of Chemistry in 2019, a portable fluorescence microarray imaging system that connects to a smartphone has been used for the detection of breast cancer gene expression.
Market Dynamics:
Driver:
Rise in the usage of microarrays in various applications
The market for microarrays has grown as a result of the growing use of microarrays in various applications. The need for microarray goods and services has increased as more scientists and organizations use them for clinical diagnostics, proteomics, genomics, and other areas. These days, microarrays are employed in many more fields, such as drug development, proteomics, clinical diagnostics, genomics, and environmental monitoring due to this diversity, the market is now more resilient to changes in certain industries and has been able to develop continuously. Drug development relies heavily on microarrays because they make target identification, toxicity assessment, and biomarker discovery easier.
Restraint:
Competition from next-generation sequencing (NGS)
Next-generation sequencing technologies can give complete molecular and genomic data; they have become more and more popular. They have so reduced microarrays' market share across a range of applications. Because of Next-generation sequencing breadth of information and high-throughput sequencing capabilities, researchers and physicians frequently use it. When considering technologies, it is frequently thought to be more potent and sophisticated than microarrays. This idea may discourage the use of microarrays in favour of next-generation sequencing in research and other settings, which might stunt the expansion of the microarray business.
Opportunity:
Growing awareness regarding personalized medicines
Molecular profiling of individual patients is the foundation of personalized medicine, which customizes medicinal interventions. In order to produce genetic and molecular data particular to each patient, microarrays are essential. The growing awareness among patients and healthcare professionals of the potential advantages of customized medicine has led to a surge in demand for these technologies. In the realm of customized medicine, interdisciplinary collaboration between researchers, healthcare practitioners, and biotechnology businesses is becoming more widespread.
Threat:
High maintenance
Microarray technology adoption may be hindered by the lack of qualified workers. If research organizations and clinical labs lack the staff with the necessary skills to properly run the technology, they can be reluctant to invest in microarray platforms. The analysis of microarray data might be challenging and call for bioinformatics knowledge. A shortage of qualified experts might lead to ineffective data processing, which would postpone research results, misunderstand them, and decrease scientific output thus hampering the market growth.
Covid-19 Impact
Through the investigation of host responses to the virus, patient gene expression alterations, and the creation of diagnostic tests, microarrays contributed to COVID-19 research. As a result, there was a rise in demand for virus-specific microarray-based tests. Thus, the pandemic caused changes in certain regions' objectives for financing research, with an emphasis on developing vaccines and researching infectious diseases. Furthermore, the market for microarrays may grow if more money is invested in life sciences research, like as proteomics and genomics, once the pandemic's acute phase has passed.
The protein microarrays segment is expected to be the largest during the forecast period
The protein microarrays segment is estimated to have a lucrative growth, as these proteomics research, protein microarrays are an effective and adaptable tool for examining the characteristics, relationships, and roles of proteins. Protein microarrays enable high-throughput analysis of the binding interactions of proteins and other molecules, much to DNA microarrays, which are used to examine gene expression. The advancement of protein microarray technology has produced increasingly sophisticated systems with improved sensitivity, specificity, and throughput.
The diseases diagnostics segment is expected to have the highest CAGR during the forecast period
The diseases diagnostics segment is anticipated to witness the highest CAGR growth during the forecast period, because the single nucleotide polymorphisms (SNPs) linked to genetic disorders, cancer, and infectious illnesses, as well as chromosomal abnormalities, are all found using these microarrays. These microarrays investigate protein-protein interactions, gene expression patterns, and protein localization in a variety of disorders using tissue slices or cultured cells. Moreover these diagnostic microarrays allow for customized treatment plans based on a patient's genetic or molecular profile in the age of personalized medicine thereby boosting the market growth.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the rising demand for cutting-edge healthcare solutions as well as enhanced genomics and personalized medicine research and development efforts are responsible for this expansion. The Asia Pacific area is home to several academic institutions, research labs, and biotechnology corporations that are actively involved in microarray research and development. This involves the creation of personalized microarrays for particular uses and the identification of biomarkers for a range of illnesses.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period; owing to one of the biggest and most developed markets for microarray technology. Particularly, the US is a significant centre for microarray creation and research. The North American microarray market is occupied by a number of multinational and local businesses that offer microarray platforms, reagents, and services. Agilent Technologies, Illumina, Thermo Fisher Scientific, PerkinElmer, and many more are some of the major companies in this sector are driving the market growth in this region.
Key players in the market
Some of the key players profiled in the Microarray Market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, Affymetrix, Merck & Co., Inc., Arrayit Corporation, Microarrays; Inc., NextGen Sciences, bioMérieux SA, RayBiotech Life, Inc, PathogenDx, Diasorin Group, Schott Minifab, Full Moon Biosystems.Inc and CapitalBio Technology Co, Ltd
Key Developments:
In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.
In October 2023, Thermo Fisher Scientific announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify patients with non-small cell lung cancer (NSCLC) with specific genomic mutations.
In September 2023, Agilent Technologies Inc recently signed a Research Collaboration Agreement (RCA) with the National Cancer Centre Singapore (NCCS) outlining their collaboration to accelerate translational cancer research on the genomic landscape of Asian-prevalent cancers over the next two years.
Products Covered:
• Consumables
• Instruments
• Software & Services
Types Covered:
• Protein Microarrays
• DNA Microarrays
• Other Microarrays
Applications Covered:
• Drug Discovery
• Diseases Diagnostics
• Research Applications
• Agriculture
• Other Applications
End Users Covered:
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutes
• Diagnostic Laboratories
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Microarray Market, By Product
5.1 Introduction
5.2 Consumables
5.3 Instruments
5.4 Software & Services
6 Global Microarray Market, By Type
6.1 Introduction
6.2 Protein Microarrays
6.3 DNA Microarrays
6.4 Other Microarrays
7 Global Microarray Market, By Application
7.1 Introduction
7.2 Drug Discovery
7.3 Diseases Diagnostics
7.4 Research Applications
7.5 Agriculture
7.6 Other Applications
8 Global Microarray Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Research & Academic Institutes
8.4 Diagnostic Laboratories
8.5 Other End Users
9 Global Microarray Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Agilent Technologies, Inc.
11.2 Thermo Fisher Scientific, Inc.
11.3 Illumina, Inc.
11.4 PerkinElmer, Inc.
11.5 Bio-Rad Laboratories
11.6 GE Healthcare
11.7 Molecular Devices, LLC
11.8 Affymetrix
11.9 Merck & Co., Inc.
11.10 Arrayit Corporation
11.11 Microarrays; Inc.
11.12 NextGen Sciences
11.13 bioMérieux SA
11.14 RayBiotech Life, Inc
11.15 PathogenDx
11.16 Diasorin Group
11.17 Schott Minifab
11.18 Full Moon Biosystems.Inc
11.19 CapitalBio Technology Co, Ltd
List of Tables
1 Global Microarray Market Outlook, By Region (2021-2030) ($MN)
2 Global Microarray Market Outlook, By Product (2021-2030) ($MN)
3 Global Microarray Market Outlook, By Consumables (2021-2030) ($MN)
4 Global Microarray Market Outlook, By Instruments (2021-2030) ($MN)
5 Global Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
6 Global Microarray Market Outlook, By Type (2021-2030) ($MN)
7 Global Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
8 Global Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
9 Global Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
10 Global Microarray Market Outlook, By Application (2021-2030) ($MN)
11 Global Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
12 Global Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
13 Global Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
14 Global Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
15 Global Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
16 Global Microarray Market Outlook, By End User (2021-2030) ($MN)
17 Global Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
18 Global Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
19 Global Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
20 Global Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
21 North America Microarray Market Outlook, By Country (2021-2030) ($MN)
22 North America Microarray Market Outlook, By Product (2021-2030) ($MN)
23 North America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
24 North America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
25 North America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
26 North America Microarray Market Outlook, By Type (2021-2030) ($MN)
27 North America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
28 North America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
29 North America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
30 North America Microarray Market Outlook, By Application (2021-2030) ($MN)
31 North America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
32 North America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
33 North America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
34 North America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
35 North America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
36 North America Microarray Market Outlook, By End User (2021-2030) ($MN)
37 North America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
38 North America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
39 North America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
40 North America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
41 Europe Microarray Market Outlook, By Country (2021-2030) ($MN)
42 Europe Microarray Market Outlook, By Product (2021-2030) ($MN)
43 Europe Microarray Market Outlook, By Consumables (2021-2030) ($MN)
44 Europe Microarray Market Outlook, By Instruments (2021-2030) ($MN)
45 Europe Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
46 Europe Microarray Market Outlook, By Type (2021-2030) ($MN)
47 Europe Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
48 Europe Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
49 Europe Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
50 Europe Microarray Market Outlook, By Application (2021-2030) ($MN)
51 Europe Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
52 Europe Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
53 Europe Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
54 Europe Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
55 Europe Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
56 Europe Microarray Market Outlook, By End User (2021-2030) ($MN)
57 Europe Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
58 Europe Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
59 Europe Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
60 Europe Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
61 Asia Pacific Microarray Market Outlook, By Country (2021-2030) ($MN)
62 Asia Pacific Microarray Market Outlook, By Product (2021-2030) ($MN)
63 Asia Pacific Microarray Market Outlook, By Consumables (2021-2030) ($MN)
64 Asia Pacific Microarray Market Outlook, By Instruments (2021-2030) ($MN)
65 Asia Pacific Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
66 Asia Pacific Microarray Market Outlook, By Type (2021-2030) ($MN)
67 Asia Pacific Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
68 Asia Pacific Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
69 Asia Pacific Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
70 Asia Pacific Microarray Market Outlook, By Application (2021-2030) ($MN)
71 Asia Pacific Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
72 Asia Pacific Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
73 Asia Pacific Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
74 Asia Pacific Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
75 Asia Pacific Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
76 Asia Pacific Microarray Market Outlook, By End User (2021-2030) ($MN)
77 Asia Pacific Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
78 Asia Pacific Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
79 Asia Pacific Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
80 Asia Pacific Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
81 South America Microarray Market Outlook, By Country (2021-2030) ($MN)
82 South America Microarray Market Outlook, By Product (2021-2030) ($MN)
83 South America Microarray Market Outlook, By Consumables (2021-2030) ($MN)
84 South America Microarray Market Outlook, By Instruments (2021-2030) ($MN)
85 South America Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
86 South America Microarray Market Outlook, By Type (2021-2030) ($MN)
87 South America Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
88 South America Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
89 South America Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
90 South America Microarray Market Outlook, By Application (2021-2030) ($MN)
91 South America Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
92 South America Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
93 South America Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
94 South America Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
95 South America Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
96 South America Microarray Market Outlook, By End User (2021-2030) ($MN)
97 South America Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
98 South America Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
99 South America Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
100 South America Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
101 Middle East & Africa Microarray Market Outlook, By Country (2021-2030) ($MN)
102 Middle East & Africa Microarray Market Outlook, By Product (2021-2030) ($MN)
103 Middle East & Africa Microarray Market Outlook, By Consumables (2021-2030) ($MN)
104 Middle East & Africa Microarray Market Outlook, By Instruments (2021-2030) ($MN)
105 Middle East & Africa Microarray Market Outlook, By Software & Services (2021-2030) ($MN)
106 Middle East & Africa Microarray Market Outlook, By Type (2021-2030) ($MN)
107 Middle East & Africa Microarray Market Outlook, By Protein Microarrays (2021-2030) ($MN)
108 Middle East & Africa Microarray Market Outlook, By DNA Microarrays (2021-2030) ($MN)
109 Middle East & Africa Microarray Market Outlook, By Other Microarrays (2021-2030) ($MN)
110 Middle East & Africa Microarray Market Outlook, By Application (2021-2030) ($MN)
111 Middle East & Africa Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
112 Middle East & Africa Microarray Market Outlook, By Diseases Diagnostics (2021-2030) ($MN)
113 Middle East & Africa Microarray Market Outlook, By Research Applications (2021-2030) ($MN)
114 Middle East & Africa Microarray Market Outlook, By Agriculture (2021-2030) ($MN)
115 Middle East & Africa Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
116 Middle East & Africa Microarray Market Outlook, By End User (2021-2030) ($MN)
117 Middle East & Africa Microarray Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
118 Middle East & Africa Microarray Market Outlook, By Research & Academic Institutes (2021-2030) ($MN)
119 Middle East & Africa Microarray Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
120 Middle East & Africa Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
